Kazia Therapeutics
KZIA
6 hedge funds and large institutions have $486K invested in Kazia Therapeutics in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
7% more capital invested
Capital invested by funds: $455K → $486K (+$31K)
14% less funds holding
Funds holding: 7 → 6 (-1)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$208K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$69.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$15.6K |
| 3 |
MWP
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
|
-$5K |
| 4 |
Citigroup
New York
|
-$977 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $291K | -$69.8K | -143 | -17% |
|
|
2
Bank of America
Charlotte,
North Carolina
| $186K | +$208K | +425 | +2,125% |
|
3
Morgan Stanley
New York
| $6K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $2K | -$15.6K | -32 | -89% |
|
5
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
MWP
6
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
| – | -$5K | -10 | Closed |
|
|
7
Citigroup
New York
| – | -$977 | -2 | -67% |
|
KZIA Hedge Fund Activity: Q4 2015 in Review
6 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q4 2015, worth a combined $486K — up 6.8% from $455K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of KZIA and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Bank of America, adding an estimated $208K. The largest seller was Renaissance Technologies, cutting an estimated $69.8K.
- 6 institutional investors held Kazia Therapeutics (KZIA) as of Q4 2015, down from 7 in Q3 2015.
- Funds reported $486K of Kazia Therapeutics stock for Q4 2015, up 6.8% quarter-over-quarter.
- 0 funds opened new Kazia Therapeutics positions in Q4 2015 and 1 closed out, a net change of -1 holder.
- The largest Kazia Therapeutics buyer in Q4 2015 was Bank of America, an estimated $208K added.
- The largest Kazia Therapeutics seller in Q4 2015 was Renaissance Technologies, an estimated $69.8K sold.
Based on aggregated 13F filings for Q4 2015.